10,911 reports of this reaction
5.9% of all BUPRENORPHINE reports
#3 most reported adverse reaction
OVERDOSE is the #3 most commonly reported adverse reaction for BUPRENORPHINE, manufactured by Purdue Pharma LP. There are 10,911 FDA adverse event reports linking BUPRENORPHINE to OVERDOSE. This represents approximately 5.9% of all 185,849 adverse event reports for this drug.
Patients taking BUPRENORPHINE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is moderately reported among BUPRENORPHINE users, representing a notable but not dominant share of adverse events.
In addition to overdose, the following adverse reactions have been reported for BUPRENORPHINE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 10,911 FDA reports for BUPRENORPHINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 5.9% of all adverse event reports for BUPRENORPHINE, making it one of the most commonly reported side effect.
If you experience overdose while taking BUPRENORPHINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.